Canopy Growth stock rises on Q1 FY27 revenue growth
Published on 09/21/2026 at 16:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCanopy Growth stock (CA1380351009) reported USD 81.2 million in first-quarter fiscal 2027 net revenue on September 21, 2026, while adjusted gross margin improved to 31 percent from 25 percent a year earlier.
Revenue and margin
According to Scanx, Canopy Growth reported USD 81.2 million in net revenue for Q1 FY27, up 13 percent from USD 71.9 million in Q1 FY26, and adjusted EBITDA loss narrowed to USD 3.2 million from USD 7.8 million.
The same report said cash stood at USD 337 million. The shift from a USD 7.8 million adjusted EBITDA loss to USD 3.2 million gives investors a clearer operating comparison than the revenue line alone.
Trading view
Reuters showed CGC.OQ at USD 0.93 on September 21, 2026, down 0.50 percent, with an intraday range of USD 0.92 to USD 0.94 and a 52-week range of USD 0.84 to USD 2.38.
For the stock, the market value still matters most: Reuters also showed the shares moving in a very low-price band around the USD 1 mark on September 21, 2026.
Market cap and range
Yahoo Finance listed Canopy Growth Corporation on September 21, 2026 with a market cap of CAD 584.089 million and a last price of CAD 1.3000 for WEED.TO. That Toronto quote underlines the gap between the Canadian listing and the US OTC-style Reuters quote for the same issuer.
Canopy Growth key data
- Company: Canopy Growth Corporation
- ISIN: CA1380351009
- Ticker: CGC
- Trading venue: Nasdaq
- Price (as of September 21, 2026): USD 0.93
- Market capitalization: CAD 584.089 million (as of September 21, 2026)
- Sector / Industry: Drug Manufacturers - Specialty & Generic
Stock stays under pressure
The Nasdaq quote of USD 0.93 on September 21, 2026 leaves Canopy Growth stock deep below its USD 2.38 52-week high and only slightly above the USD 0.84 low. That price structure keeps the market focused on the company's cash balance and margin trend rather than on headline revenue growth.
